Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for alcohol consumption reduction
NCT00630955Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2006
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in alcohol use disorder (AUD), sponsored by Yale University. Started Jun 2006; status: completed.
02
Drugs
memantine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00630955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630955.